Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study

Can Sheng1, Li Lin1, Hua Lin1

  • 1Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.

Abstract

Insights

Gut microbiota composition changes in individuals with subjective cognitive decline (SCD), a preclinical stage of Alzheimer's disease (AD). The anti-inflammatory genus Faecalibacterium was significantly decreased in SCD, suggesting a link between gut health and early AD.

Area of Science:

  • Microbiome research
  • Neuroscience
  • Gastroenterology

Background:

  • Subjective cognitive decline (SCD) is the earliest indicator of preclinical Alzheimer's disease (AD).
  • Gut microbiota alterations are implicated in mild cognitive impairment (MCI) and AD dementia.
  • The specific changes in gut microbial composition in individuals with SCD are not well understood.

Purpose of the Study:

  • To characterize the gut microbiota in individuals experiencing subjective cognitive decline.
  • To investigate the relationship between gut microbial composition and cognitive performance in early AD stages.

Main Methods:

  • 16S rRNA Illumina Miseq sequencing of fecal samples from 105 participants (38 normal controls, 53 SCD, 14 cognitive impairment).
  • Comparative analysis of gut microbial compositions across the three groups.
  • Association analysis between altered gut microbiota and cognitive performance, with amyloid PET validation in selected SCD individuals.

Main Results:

  • A progressive decline in the abundance of Firmicutes, Clostridia, Clostridiales, Ruminococcaceae, and Faecalibacterium was observed from normal controls to SCD and cognitive impairment groups.
  • The anti-inflammatory genus Faecalibacterium was significantly reduced in individuals with SCD compared to normal controls.
  • Altered bacterial taxa were associated with cognitive performance, and findings were consistent in SCD participants with positive amyloid evidence.

Conclusions:

  • Gut microbiota composition is altered in individuals with subjective cognitive decline.
  • These alterations may offer novel insights into the pathophysiological mechanisms of Alzheimer's disease.
  • This study highlights the potential role of the gut microbiome in the early stages of AD.